Patent: 10,563,172
✉ Email this page to a colleague
Summary for Patent: 10,563,172
| Title: | Methods of T cell expansion and activation |
| Abstract: | The present disclosure relates to methods, cells, and compositions for preparing T cell populations and compositions for adoptive cell therapy. In particular, provided herein are methods for efficiently expanding and activating T cell populations for genetic engineering and adoptive T cell immunotherapies. Also provided are cells and compositions produced by the methods and methods of their use. |
| Inventor(s): | Peiman Hematti, Debra Bloom |
| Assignee: | Wisconsin Alumni Research Foundation |
| Application Number: | US15/458,339 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,563,172
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Bluebird Bio Inc. | SKYSONA | elivaldogene autotemcel | Injection | 125755 | September 16, 2022 | ⤷ Start Trial | 2037-03-14 |
| Genetix Biotherapeutics Inc. | SKYSONA | elivaldogene autotemcel | Injection | 125755 | 16-Sep-22 | ⤷ Start Trial | 2037-03-14 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,563,172
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 3017603 | ⤷ Start Trial |
| European Patent Office | 3430130 | ⤷ Start Trial |
| Japan | 2019508056 | ⤷ Start Trial |
| Japan | 2022023136 | ⤷ Start Trial |
| Japan | 2024091728 | ⤷ Start Trial |
| Japan | 6963560 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
